SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001214659-23-002281
Filing Date
2023-02-14
Accepted
2023-02-14 14:23:26
Documents
1
Group Members
CHEN YUTCG CROSSOVER FUND I, L.P.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 silence213230sc13ga1.htm SC 13G/A 80790
  Complete submission text file 0001214659-23-002281.txt   82287
Mailing Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH 44-0-20-3457 6900
Silence Therapeutics plc (Subject) CIK: 0001479615 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13G/A | Act: 34 | File No.: 005-92205 | Film No.: 23627111
SIC: 2834 Pharmaceutical Preparations

Mailing Address 228 HAMILTON AVENUE, 3RD FLOOR PALO ALTO CA 94301
Business Address 228 HAMILTON AVENUE, 3RD FLOOR PALO ALTO CA 94301 650-798-5495
TCG Crossover GP I, LLC (Filed by) CIK: 0001839947 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A